Real-time enrollment status for this duchenne muscular dystrophy clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 5:42 AM UTC
| NCT Number | NCT04906460 |
| Recruiting Status | Recruiting |
| Condition | Duchenne Muscular Dystrophy |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Wave Life Sciences USA, Inc. |
| Last Updated on CT.gov | December 15, 2025 (Dec 15, 2025) |
As of August 30, 2026: Clinical trial NCT04906460 is currently recruiting participants. This phase1 study for duchenne muscular dystrophy is actively seeking new participants at 2 locations across the United States. The study is sponsored by Wave Life Sciences USA, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04906460 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04906460 was last updated Dec 15, 2025 (December 15, 2025). HelloStudys verifies this status automatically.